Pharmaceutical Companies Choke on Sales Data

By Eric Newmark – August 24, 2009
Photo of Eric NewmarkOffline

A well known challenge for pharmaceutical companies is visibility into product sales and supply chain movement. Although the industry lacks item-level visibility (the root of industry visibility issues), pharmaceutical manufacturers actually have access to a tremendous amount of sales data and product movement-related information through both fee-for-service agreements (more specifically 867 data) and data delivery services such as IMS.  However, despite differences in the types of sales information th

 

About the author

Eric Newmark

Program Vice President, SaaS, Enterprise Applications, and Industry CloudIDC

8 Comments

Offline Bob Merold said 9 years ago

Photo of Eric NewmarkOffline Eric Newmark said 9 years ago

Offline R. Arun Kumar said 9 years ago

Photo of Eric NewmarkOffline Eric Newmark said 9 years ago

Post a comment

Form Signatures

Viewed 1,720 times